Chris Seifarth

Chris  brings more than 28 years of biotechnology, pharmaceutical device and consulting experience in small, mid-size and large companies with expertise in Clinical Operations, Regulatory Affairs, Quality Assurance/Compliance, Due Diligence, Acquisitions/Integrations, Regulatory Inspections, and Remediation. He has extensive knowledge of drug development from concept through product lifecycle, including organic development, in-licensing, quality system analysis, team leadership, vendor relations and has supported clinical and commercial stage programs and indications in the U.S. and abroad.

Chris has extensive business and project coordination experience and has held key leadership roles in developing and facilitating infrastructure build out, organizational structure, establishing systems and business processes in support of growing academic research, medical device, Pharma, and Biotech organizations across a wide range of therapeutic areas including cancer, multiple sclerosis, Duchene’s muscular dystrophy, neurofibromatosis Type 2 (NF2), and other life-threatening or disabling conditions. Chris holds a MS degree from Temple University’s School of Pharmacy in Pharmaceutical Quality Assurance and Regulatory Affairs.